Physician profile
Joseph Zavatsky
NPI 1619184371
$205,062.49
in general payments reported to CMS, 2019-2025
10 companies · $2,915 in 2025
The $2,915 reported for 2025 was more than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $140K · 2020: $20K · 2022: $24K · 2023: $14K · 2024: $4,572 · 2025: $2,915.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $21K · Food and Beverage: $86.29.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $21,049.58 |
| Food and Beverage | $86.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Products, INC. | $110,515.00 | 2019 | |
| Zimmer Biomet Holdings, INC. | $50,695.00 | 2019-2022 | |
| Zimvie INC. | $36,075.57 | 2022-2023 | |
| Highridge Medical LLC | $7,400.70 | 2024-2025 | Trelloss-C Sa |
| Medtronic USA, INC. | $211.52 | 2019 | |
| Alon Medical Technology | $62.29 | 2025 | |
| Integrity Implants INC. | $44.41 | 2019 | |
| Arthrex, INC. | $24.00 | 2025 | |
| Stryker Corporation | $21.18 | 2019 | |
| Centinel Spine, LLC | $12.82 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Zavatsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.